Tukysa + Standard Care Improves Survival for HER2+ Brain Mets
moderators
Posts: 9,581
Tukysa Plus Standard Care Improves Survival in People With HER2-Positive Brain Mets
Feb 27, 2023
Tukysa plus the standard of care improved survival in people diagnosed with metastatic, HER2-positive breast cancer that had spread to the brain. Read more...
0
Categories
Join Us on Zoom: Upcoming virtual support groups. Read more...
Share more about you! Fill out your NEW profile.